Conexiant’s news site is now MDSpire News. Learn more
Advertisement
Video: The Ultimate in Translational Medicine – with Harold Keer
Power List 2026 honoree Harold Keer traces oncology’s transformation – and considers what it will take to turn today’s “abundance of riches” into better patient outcomes
Harold Keer describes industry as a way to scale individual discoveries into medicines for patients, calling it “the ultimate translational medicine.”.
2
Cancer treatment has expanded from cytotoxic chemotherapy to targeted therapies, monoclonal antibodies, immunotherapies, bispecific antibodies, and antibody-drug conjugates.
3
RAS, once considered an “undruggable” target, is now a competitive area of drug development.
4
Keer discusses why promising cancer programs fail and the promise and possible “irrational exuberance” surrounding emerging treatment modalities.
5
Keer says his unfinished business is helping Taiho’s newly acquired antibody-drug conjugate technology reach the clinic.
